The Association of Early Pregnancy Units

GEM3 Trial

Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial

GEM3 Trial

Current Status: The GEM3 Trial results were published in the Lancet in 2023. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02478-3/fulltext
Picture of aepudev

aepudev

Join Our Supportive Network Today

Connect with us to enhance early pregnancy care and support for women across the UK.

Contact

AEPU Trainee Education Working Group

We are excited to open applications to join the AEPU Trainee Education Working Group.

Following the approval of our educational curriculum by the AEPU executive committee, we now anticipate this will form the basis of content development that will improve early pregnancy training for trainees and associated healthcare professionals. The deadline for applications is the 3rd April 2026.

Click here for instructions